Shuwen Sun
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Shuwen Sun has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
Kai Gong
Department of Neurosurgery, The Affiliated Jiangyin Hospital of Nantong University, 214400 Jiangyin, China
9 shared publicationsXiaobin Fei
Department of Neurosurgery, The Affiliated Jiangyin Hospital of Nantong University, 214400 Jiangyin, China
9 shared publicationsXin Huang
Department of Neurosurgery, The Affiliated Jiangyin Hospital of Nantong University, 214400 Jiangyin, China
8 shared publicationsHeng Gao
Department of Neurosurgery, The Affiliated Jiangyin Hospital of Nantong University, Jiangyin, China
3 shared publications- Hengzhu Zhang
Northern Jiangsu People’s Hospital Affiliated to Yangzhou University, Yangzhou, China
3 shared publications Xiaodong Wang
Department of Neurosurgery, The Clinical Medical College of Yangzhou University, Yangzhou, China
3 shared publications
Latest Publications
- 11 April 2026
- Published by Elsevier in Journal of Clinical Neuroscience
- Vol. 149, 112031
Early hemoglobin levels and mortality in non-transfused TBI patients: A linear, inverse association
- 11 April 2026
- Published by Elsevier in Journal of Clinical Neuroscience
- Vol. 149, 112031
Early hemoglobin levels and mortality in non-transfused TBI patients: A linear, inverse association
- Open Access
- 11 February 2026
- Published by Springer Nature in European Journal of Medical Research
- Vol. 31 (1)
Early serum sodium variability and mortality in critically ill patients with cerebral infarction: a retrospective cohort study
Dysnatremia is common in cerebral infarction and associated with poor outcomes. However, the prognostic significance of early dynamic changes in serum sodi
- 11 February 2026
- Published by Springer Nature in European Journal of Medical Research
- Vol. 31 (1)
Open AccessEarly serum sodium variability and mortality in critically ill patients with cerebral infarction: a retrospective cohort study
Dysnatremia is common in cerebral infarction and associated with poor outcomes. However, the prognostic significance of early dynamic changes in serum sodi
- 15 January 2026
- Published by Springer Nature in Neurological Sciences
- Vol. 47 (1) , 166
Hemoglobin glycation index predicts mortality in intracerebral hemorrhage: a nonlinear threshold effect
Background The Hemoglobin Glycation Index (HGI), integrating acute and chronic glycemic dysregulation, may reflect metabolic state in critical illness. We aimed to evaluate whether HGI predicts 30-day mortality in intracerebral hemorrhage (ICH) patients and identify potential threshold effects. Methods We analyzed 1351 ICH patients from the MIMIC-IV database. HGI was calculated as the difference between observed and predicted hemoglobin A1c (HbA1c), derived from admission glucose. Patients were stratified into HGI quartiles (Q1–Q4). The primary outcome was 30-day mortality, assessed using Cox regression models adjusted for demographics, comorbidities, and severity scores. Nonlinear relationships were evaluated with restricted cubic splines and threshold effect analysis. Results The cohort exhibited a nonlinear, L-shaped association between HGI and mortality (P for nonlinearity = 0.0008). Compared to Q4 (highest HGI), Q1 (lowest HGI) had a 53% higher mortality risk (adjusted HR 0.47, 95% CI 0.32–0.68, P < 0.001). A threshold effect was identified at HGI = 0.78: below this value, each unit increase in HGI reduced mortality by 24% (HR 0.76, 95% CI 0.68–0.85, P < 0.001), while no significant association existed above it (HR 1.11, P = 0.319). Subgroup analyses confirmed robustness across age, diabetes status, and neurological severity, with a pronounced protective effect in males (P for interaction = 0.038). Conclusions Low HGI independently predicts increased 30-day mortality in ICH, with a critical threshold at 0.78. HGI may represent a potential biomarker for metabolic risk stratification in neurocritical care, offering insights beyond conventional glycemic metrics.
- 15 January 2026
- Published by Springer Nature in Neurological Sciences
- Vol. 47 (1) , 166
Hemoglobin glycation index predicts mortality in intracerebral hemorrhage: a nonlinear threshold effect
Background The Hemoglobin Glycation Index (HGI), integrating acute and chronic glycemic dysregulation, may reflect metabolic state in critical illness. We aimed to evaluate whether HGI predicts 30-day mortality in intracerebral hemorrhage (ICH) patients and identify potential threshold effects. Methods We analyzed 1351 ICH patients from the MIMIC-IV database. HGI was calculated as the difference between observed and predicted hemoglobin A1c (HbA1c), derived from admission glucose. Patients were stratified into HGI quartiles (Q1–Q4). The primary outcome was 30-day mortality, assessed using Cox regression models adjusted for demographics, comorbidities, and severity scores. Nonlinear relationships were evaluated with restricted cubic splines and threshold effect analysis. Results The cohort exhibited a nonlinear, L-shaped association between HGI and mortality (P for nonlinearity = 0.0008). Compared to Q4 (highest HGI), Q1 (lowest HGI) had a 53% higher mortality risk (adjusted HR 0.47, 95% CI 0.32–0.68, P < 0.001). A threshold effect was identified at HGI = 0.78: below this value, each unit increase in HGI reduced mortality by 24% (HR 0.76, 95% CI 0.68–0.85, P < 0.001), while no significant association existed above it (HR 1.11, P = 0.319). Subgroup analyses confirmed robustness across age, diabetes status, and neurological severity, with a pronounced protective effect in males (P for interaction = 0.038). Conclusions Low HGI independently predicts increased 30-day mortality in ICH, with a critical threshold at 0.78. HGI may represent a potential biomarker for metabolic risk stratification in neurocritical care, offering insights beyond conventional glycemic metrics.
- 21 August 2025
- Published by Springer Nature in Neurosurgical Review
- Vol. 48 (1) , 1-13
Dynamic sodium dysregulation predicts mortality in intracerebral hemorrhage: A retrospective cohort study of temporal variability and absolute thresholds
Dysnatremia and sodium variability are emerging prognostic markers in neurocritical care, yet their role in intracerebral hemorrhage (ICH) remains underexplored. This study investigates the independent and synergistic effects of serum sodium variability (coefficient of variation, CV) and absolute sodium levels on mortality in ICH patients. We conducted a retrospective cohort study using data from the Medical Information Mart for Intensive Care (MIMIC-IV) database. Sodium variability was quantified as CV, while mean sodium levels were categorized into normonatremia (135–145 mmol/L), hyponatremia (< 135 mmol/L), and hypernatremia (> 145 mmol/L). Outcomes included 30-day, in-hospital, and ICU mortality. Multivariable Cox models adjusted for demographics, disease severity, and interventions. A total of 2044 ICH patients were included in the study. Increased sodium variability exhibited a robust linear association with mortality, with each 1% rise in CV independently predicting a 38% higher 30-day mortality risk (adjusted HR 1.38, 95% CI 1.31–1.46; P < 0.001). Patients in the highest CV quartile (Q4) faced a 2.48-fold mortality risk compared to the lowest quartile (Q1). Hypernatremia (> 145 mmol/L) emerged as a potent independent predictor of mortality (HR 2.93, 95% CI 2.43–3.52; P < 0.001), whereas hyponatremia showed non-significant trends (HR 1.17, 0.85–1.61). Restricted cubic spline analyses revealed a U-shaped relationship between mean sodium levels and mortality, with 140.7 mmol/L as the optimal threshold, while sodium variability demonstrated a linear dose-response effect. Both sodium variability and hypernatremia independently predict mortality in ICH, with CV demonstrating a linear dose-response relationship and absolute levels showing a U-shaped risk curve. These findings advocate for dual monitoring of sodium homeostasis to guide precision fluid management in ICH.
- 21 August 2025
- Published by Springer Nature in Neurosurgical Review
- Vol. 48 (1) , 1-13
Dynamic sodium dysregulation predicts mortality in intracerebral hemorrhage: A retrospective cohort study of temporal variability and absolute thresholds
Dysnatremia and sodium variability are emerging prognostic markers in neurocritical care, yet their role in intracerebral hemorrhage (ICH) remains underexplored. This study investigates the independent and synergistic effects of serum sodium variability (coefficient of variation, CV) and absolute sodium levels on mortality in ICH patients. We conducted a retrospective cohort study using data from the Medical Information Mart for Intensive Care (MIMIC-IV) database. Sodium variability was quantified as CV, while mean sodium levels were categorized into normonatremia (135–145 mmol/L), hyponatremia (< 135 mmol/L), and hypernatremia (> 145 mmol/L). Outcomes included 30-day, in-hospital, and ICU mortality. Multivariable Cox models adjusted for demographics, disease severity, and interventions. A total of 2044 ICH patients were included in the study. Increased sodium variability exhibited a robust linear association with mortality, with each 1% rise in CV independently predicting a 38% higher 30-day mortality risk (adjusted HR 1.38, 95% CI 1.31–1.46; P < 0.001). Patients in the highest CV quartile (Q4) faced a 2.48-fold mortality risk compared to the lowest quartile (Q1). Hypernatremia (> 145 mmol/L) emerged as a potent independent predictor of mortality (HR 2.93, 95% CI 2.43–3.52; P < 0.001), whereas hyponatremia showed non-significant trends (HR 1.17, 0.85–1.61). Restricted cubic spline analyses revealed a U-shaped relationship between mean sodium levels and mortality, with 140.7 mmol/L as the optimal threshold, while sodium variability demonstrated a linear dose-response effect. Both sodium variability and hypernatremia independently predict mortality in ICH, with CV demonstrating a linear dose-response relationship and absolute levels showing a U-shaped risk curve. These findings advocate for dual monitoring of sodium homeostasis to guide precision fluid management in ICH.
- 21 May 2025
- Published by Springer Nature in Neurosurgical Review
- Vol. 48 (1) , 1-11
Serum creatinine-to-albumin ratio predicts mortality in hemorrhagic stroke: a novel threshold for risk stratification
Hemorrhagic stroke (HS) is a life-threatening condition with high mortality, particularly in intensive care unit (ICU) settings. The serum creatinine-to-albumin ratio (CAR) has emerged as a novel biomarker integrating renal dysfunction and systemic inflammation, but its prognostic value in HS remains underexplored. This retrospective cohort study analyzed data from the Medical Information Mart for Intensive Care IV (MIMIC-IV) database. We included 1,046 adult ICU patients with HS (intracerebral or subarachnoid hemorrhage) and stratified them by CAR quartiles. The primary outcome was 28-day all-cause mortality (ACM). Multivariable Cox regression models adjusted for age, Glasgow Coma Scale (GCS) score, and comorbidities were used to assess associations. Predictive performance was evaluated using receiver operating characteristic (ROC) curves and restricted cubic spline (RCS) analysis. The 28-day mortality increased significantly across CAR quartiles (Q1-Q4: 21.8%, 19.1%, 36.0%, and 40.8%, respectively; P for trend < 0.001). In the fully adjusted model (Model 3), patients in the highest CAR quartile (Q4) had a 2.30-fold higher mortality risk (95% CI: 1.58–3.35; P < 0.001) compared to Q1. CAR demonstrated significantly higher discriminative ability (AUC = 0.612, 95% CI: 0.574–0.650) compared to isolated creatinine (AUC = 0.568) or albumin (AUC = 0.371) measurements (P < 0.01). RCS analysis revealed a nonlinear relationship, with CAR > 0.25 marking a critical threshold for increased mortality risk. CAR is an independent predictor of 28-day mortality in critically ill patients with HS, outperforming traditional single biomarkers. Its clinical accessibility and robust prognostic performance suggest potential utility for early risk stratification and personalized treatment strategies in HS management.
- 21 May 2025
- Published by Springer Nature in Neurosurgical Review
- Vol. 48 (1) , 1-11
Serum creatinine-to-albumin ratio predicts mortality in hemorrhagic stroke: a novel threshold for risk stratification
Hemorrhagic stroke (HS) is a life-threatening condition with high mortality, particularly in intensive care unit (ICU) settings. The serum creatinine-to-albumin ratio (CAR) has emerged as a novel biomarker integrating renal dysfunction and systemic inflammation, but its prognostic value in HS remains underexplored. This retrospective cohort study analyzed data from the Medical Information Mart for Intensive Care IV (MIMIC-IV) database. We included 1,046 adult ICU patients with HS (intracerebral or subarachnoid hemorrhage) and stratified them by CAR quartiles. The primary outcome was 28-day all-cause mortality (ACM). Multivariable Cox regression models adjusted for age, Glasgow Coma Scale (GCS) score, and comorbidities were used to assess associations. Predictive performance was evaluated using receiver operating characteristic (ROC) curves and restricted cubic spline (RCS) analysis. The 28-day mortality increased significantly across CAR quartiles (Q1-Q4: 21.8%, 19.1%, 36.0%, and 40.8%, respectively; P for trend < 0.001). In the fully adjusted model (Model 3), patients in the highest CAR quartile (Q4) had a 2.30-fold higher mortality risk (95% CI: 1.58–3.35; P < 0.001) compared to Q1. CAR demonstrated significantly higher discriminative ability (AUC = 0.612, 95% CI: 0.574–0.650) compared to isolated creatinine (AUC = 0.568) or albumin (AUC = 0.371) measurements (P < 0.01). RCS analysis revealed a nonlinear relationship, with CAR > 0.25 marking a critical threshold for increased mortality risk. CAR is an independent predictor of 28-day mortality in critically ill patients with HS, outperforming traditional single biomarkers. Its clinical accessibility and robust prognostic performance suggest potential utility for early risk stratification and personalized treatment strategies in HS management.
- 26 April 2024
- Published by Elsevier in World Neurosurgery
- Vol. 187, e585-e597
Neuroendoscopic Surgery Versus Stereotactic Aspiration in the Treatment of Supratentorial Intracerebral Hemorrhage: A Meta-Analysis
- 26 April 2024
- Published by Elsevier in World Neurosurgery
- Vol. 187, e585-e597
Neuroendoscopic Surgery Versus Stereotactic Aspiration in the Treatment of Supratentorial Intracerebral Hemorrhage: A Meta-Analysis
- Open Access
- 20 October 2022
- Published by Springer Nature in Research Square
Neuroendoscopic Surgery versus Stereotactic Aspiration in the treatment of supratentorial intracerebral hemorrhage: a meta-analysis
Background No consensus has been reached on the superiority between Neuroendoscopic Surgery (NS) versus Stereotactic Aspiration (SA) in the treatment of supratentorial intracerebral hemorrhage (ICH). Therefore, this study conducted in-depth analysis and aimed to evaluate the efficacy and safety of NS versus SA for supratentorial ICH. Methods We searched for the all-relevant studies systematically from English databases including PubMed, Embase, Web of Science and the Cochrane Library. Two independent researchers identified and selected these literatures that met the inclusion criteria. Then we evaluated the quality of these studies according to the Cochrane Collaboration’s risk of bias tool and the Newcastle-Ottawa Scale. RevMan 5.4 statistical software was used to conduct this meta-analysis. Results Fifteen studies, including 2600 supratentorial ICH patients, were included in our meta-analysis. The pooled results showed that NS could effectively reduce the postoperative mortality (P < 0.00001) and increase the hematoma evacuation rate (P < 0.00001). However, no significant difference was found between NS and SA in improving the functional prognosis (P = 0.15). In the aspect of hospital stays (P < 0.00001), no enough evidence could support that SA could shorten the hospital stays better than NS. However, SA had more advantages in shortening operation time (P < 0.00001) and reducing intraoperative blood loss (P < 0.00001). In the aspect of complications, NS could have a positive effect on preventing intracranial infection (P = 0.004). In the subgroup analysis, we found that Initial GCS might be a risk factor affecting prognosis and hematoma volume might be an important factor affecting mortality. Conclusion NS might have more advantages than SA in the treatment of supratentorial ICH. However, SA was also an effective alternative for middle-aged and elderly patients. More high-quality studies were needed to verify our conclusions in the future.
- 20 October 2022
- Published by Springer Nature in Research Square
Open AccessNeuroendoscopic Surgery versus Stereotactic Aspiration in the treatment of supratentorial intracerebral hemorrhage: a meta-analysis
Background No consensus has been reached on the superiority between Neuroendoscopic Surgery (NS) versus Stereotactic Aspiration (SA) in the treatment of supratentorial intracerebral hemorrhage (ICH). Therefore, this study conducted in-depth analysis and aimed to evaluate the efficacy and safety of NS versus SA for supratentorial ICH. Methods We searched for the all-relevant studies systematically from English databases including PubMed, Embase, Web of Science and the Cochrane Library. Two independent researchers identified and selected these literatures that met the inclusion criteria. Then we evaluated the quality of these studies according to the Cochrane Collaboration’s risk of bias tool and the Newcastle-Ottawa Scale. RevMan 5.4 statistical software was used to conduct this meta-analysis. Results Fifteen studies, including 2600 supratentorial ICH patients, were included in our meta-analysis. The pooled results showed that NS could effectively reduce the postoperative mortality (P < 0.00001) and increase the hematoma evacuation rate (P < 0.00001). However, no significant difference was found between NS and SA in improving the functional prognosis (P = 0.15). In the aspect of hospital stays (P < 0.00001), no enough evidence could support that SA could shorten the hospital stays better than NS. However, SA had more advantages in shortening operation time (P < 0.00001) and reducing intraoperative blood loss (P < 0.00001). In the aspect of complications, NS could have a positive effect on preventing intracranial infection (P = 0.004). In the subgroup analysis, we found that Initial GCS might be a risk factor affecting prognosis and hematoma volume might be an important factor affecting mortality. Conclusion NS might have more advantages than SA in the treatment of supratentorial ICH. However, SA was also an effective alternative for middle-aged and elderly patients. More high-quality studies were needed to verify our conclusions in the future.
- 1 February 2020
- Published by Elsevier in World Neurosurgery
- Vol. 134, 477-488
Neuroendoscopic Surgery versus Craniotomy for Supratentorial Hypertensive Intracerebral Hemorrhage: A Systematic Review and Meta-Analysis
- 1 February 2020
- Published by Elsevier in World Neurosurgery
- Vol. 134, 477-488
Neuroendoscopic Surgery versus Craniotomy for Supratentorial Hypertensive Intracerebral Hemorrhage: A Systematic Review and Meta-Analysis